Fund Name | : | UTI Mutual Fund |
Scheme Name | : | UTI-Healthcare Fund - Direct (G) |
AMC | : | UTI Mutual Fund |
Type | : | O |
Category | : | Equity - Pharma |
Launch Date | : | 01-Jan-2013 |
Fund Manager | : | Kamal Gada |
Net Assets (Rs. cr) | : | 947.26 |
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
NAV Date | : | 22-Apr-2024 |
NAV [Rs.] | : | 246.21 |
Buy/Resale Price [Rs.] | : | 0 |
Sell/Repurchase Price [Rs.] | : | 0 |
Entry Load % | : | |
Exit Load % | : |
1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
---|---|---|---|---|---|---|---|---|
Scheme Returns | 0.21 | 0.48 | 4.78 | 21.43 | 49.46 | 14.68 | 22.15 | 15.62 |
Category Avg | -1.75 | 2.39 | 4.75 | 21.86 | 48.93 | 15.89 | 22.98 | 18.74 |
Category Best | -0.47 | 6.66 | 7.70 | 26.46 | 57.12 | 18.83 | 27.18 | 36.35 |
Category Worst | 0.21 | 0.48 | 4.78 | 21.43 | 49.46 | 14.68 | 22.15 | 15.62 |
Dividends | Bonus |
---|
No Record Found
Min. Investment(Rs.) | : | 5000 |
Increm.Investment(Rs.) | : | 1000 |
Calculate the worth of your wealth at retirement
In | |
Name of the Company | No of shares |
No Record Found
Out | |
Name of the Company | No of shares |
No Record Found
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) | ||||
---|---|---|---|---|---|---|---|---|---|
Equity & Equity related Investments | |||||||||
Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.56 | 7,92,859.00 | 128.49 | ||||
Equity | Cipla | Pharmaceuticals & Biotechnology | 7.15 | 4,52,551.00 | 67.74 | ||||
Equity | Apollo Hospitals | Healthcare Services | 6.88 | 1,02,457.00 | 65.13 | ||||
Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 5.91 | 2,51,023.00 | 56.00 | ||||
Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.49 | 84,499.00 | 52.03 | ||||
Equity | Fortis Health. | Healthcare Services | 3.55 | 8,00,000.00 | 33.62 | ||||
Equity | Krishna Institu. | Healthcare Services | 3.48 | 1,60,000.00 | 32.95 | ||||
Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 3.45 | 3,00,000.00 | 32.66 | ||||
Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 3.16 | 1,15,000.00 | 29.91 | ||||
Equity | Suven Pharma | Pharmaceuticals & Biotechnology | 3.15 | 4,40,000.00 | 29.79 | ||||
Equity | ERIS Lifescience | Pharmaceuticals & Biotechnology | 2.94 | 3,30,000.00 | 27.83 | ||||
Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.92 | 1,50,000.00 | 27.68 | ||||
Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.65 | 2,48,941.00 | 25.08 | ||||
Equity | Metropolis Healt | Healthcare Services | 2.36 | 1,29,631.00 | 22.34 | ||||
Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 2.35 | 64,713.00 | 22.30 | ||||
Equity | P & G Health Ltd | Pharmaceuticals & Biotechnology | 2.33 | 46,865.00 | 22.07 | ||||
Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.22 | 1,70,000.00 | 21.04 | ||||
Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.03 | 38,900.00 | 19.22 | ||||
Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 1.80 | 1,77,744.00 | 17.04 | ||||
Equity | Jupiter Life Lin | Healthcare Services | 1.70 | 1,34,511.00 | 16.09 | ||||
Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.68 | 38,000.00 | 15.94 | ||||
Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 1.61 | 1,00,000.00 | 15.21 | ||||
Equity | Syngene Intl. | Healthcare Services | 1.58 | 2,13,138.00 | 14.97 | ||||
Equity | Caplin Point Lab | Pharmaceuticals & Biotechnology | 1.39 | 1,00,000.00 | 13.15 | ||||
Equity | Aster DM Health. | Healthcare Services | 1.34 | 3,10,000.00 | 12.69 | ||||
Equity | Marksans Pharma | Pharmaceuticals & Biotechnology | 1.33 | 8,31,138.00 | 12.63 | ||||
Equity | Ami Organics | Pharmaceuticals & Biotechnology | 1.27 | 1,10,069.00 | 12.04 | ||||
Equity | Alembic Pharma | Pharmaceuticals & Biotechnology | 1.25 | 1,20,000.00 | 11.82 | ||||
Equity | Windlas Biotech | Pharmaceuticals & Biotechnology | 1.16 | 2,15,400.00 | 10.99 | ||||
Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.15 | 4,000.00 | 10.85 | ||||
Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 1.12 | 1,01,888.00 | 10.65 | ||||
Equity | Rainbow Child. | Healthcare Services | 1.10 | 80,000.00 | 10.38 | ||||
Equity | Poly Medicure | Healthcare Equipment & Supplies | 1.05 | 62,328.00 | 9.91 | ||||
Equity | Max Healthcare | Healthcare Services | 0.78 | 90,000.00 | 7.38 | ||||
Equity | Sequent Scien. | Pharmaceuticals & Biotechnology | 0.76 | 6,20,305.00 | 7.16 | ||||
Equity | Vijaya Diagnost. | Healthcare Services | 0.59 | 87,917.00 | 5.60 | ||||
Equity | Star Health Insu | Insurance | 0.57 | 1,00,000.00 | 5.43 | ||||
Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.55 | 1,59,594.00 | 5.25 | ||||
Cash & Cash Equivalent | |||||||||
Net CA & Others | Net CA & Others | -/- | 0.52 | 0.00 | 4.90 | ||||
Money Market Investments | |||||||||
T Bills | TBILL-364D | -/- | 0.13 | 1,30,00,000.00 | 1.23 | ||||
Term Deposits | |||||||||
Fixed Deposits | C C I | -/- | 0.01 | 0.00 | 0.09 |
Fund House | : UTI Asset Management Company Ltd |
Incorporation Date | : 14-Nov-2002 |
Total Assets Managed (Cr.) | : 2,90,993.03 |
Trustee/s | : UTI Tustee Company Pvt. L |
Chairman | : N/A |
CEO / MD | : Mr.Imtaiyazur Rahman |
CIO | : N/A |
President | : Mr. Debashish Mohanty |
Director/s | : Mr. Flemming Madsen |
Compliance Officer/s | : Ms. Suruchi wanare |
Investor Service Officer/s | : Ms.Madhavi Dicholkar |
Fund Manager/s | : Kamal Gada |
Auditors | : S.R.Batliboi & co.LLp |
Registered Office | : UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 |
Contact Nos | : 66786666 |
Fax | : 66786503;66786578 |
: service@uti.co.in | |
Website | : www.utimf.com |
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.